Stanford chemists have developed a potential new strategy for fighting antibiotic-resistant bacterium — adding a new molecule onto an existing antibiotic.
Category: Drug Development
Stanford researchers find that small molecule may help treat enzyme deficiency
Stanford researchers have identified a small molecule that may help curb some of the symptoms of a genetic deficiency in glucose-6-phosphate dehydrogenase.
Stanford scientist is working to halt spread of hepatitis B
Decision scientist Mehlika Toy is working with the WHO to help eliminate the public health burden of hepatitis B by the year 2030.
Turning molecules into medicine with SPARK
As someone who had spent her career studying molecules on a computer screen, experiments involving people were a revelation and inspiration for Jane Tseng, PhD, …
“Mood mirror” in blood: Might its absence bring on the blues?
Low levels of a substance, acetyl-L-carnitine, in the blood are associated with depression. Could this "mood mirror" be a cure for the blues?
CRISPR helps scientists track down potential therapeutic targets for ALS
Scientists have used genome editing to pinpoint genes that reveal information about ALS and may even protect against the degeneration of neurons.
The efficacy of antidepressants: A Q&A with John Ioannidis
In a meta-analysis of more than 500 clinical trials, researchers have new conclusions about the efficacy of 21 different antidepressants.